회사 개요
HCM III Acquisition Corp. (HCMA) is a special purpose acquisition company (SPAC) dedicated to completing a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization with one or more target businesses to create a publicly traded entity. The company operates within the Financial Services sector and specifically falls under the industry classification of Shell Companies, a designation that signifies it currently functions as a blank-check vehicle awaiting a business combination rather than operating a traditional revenue-generating business. As of the latest available data, the company's market capitalization stands at $341.04M, while its incorporated status in 2025 and headquarters in Stamford, Connecticut, define its legal and operational framework. The reported annual revenue is not disclosed in the current financial statements, and the employee count is listed as N/A, which indicates that the company has not yet deployed capital to build a workforce or operational infrastructure prior to its merger. These valuation and structural metrics collectively indicate that HCMA exists primarily as a financial shell designed to facilitate a transaction, and its current market cap reflects the trust account value and premium investors are willing to pay for the potential of an upcoming business combination rather than existing operational earnings.
재무 건전성
The reported revenue for the trailing twelve months is N/A, reflecting the pre-merger status where traditional sales figures do not yet apply, yet the company has recorded a net income of $2.92M which appears anomalous for a SPAC without operations and suggests potential accounting adjustments or specific trust account interest income. The EBITDA metric is listed as N/A, meaning the company has not yet generated operating earnings from commercial activities to support a meaningful EBITDA calculation. The free cash flow is also N/A, indicating that the company has not yet produced positive cash flows from operations and remains reliant on its initial public offering proceeds or trust account funds. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which confirms the absence of commercial revenue streams and implies that any current income is non-operational or derived from financial instruments rather than business sales. The company holds $1.02M in cash and carries $0 in debt, resulting in a debt-to-equity ratio that is N/A due to the lack of equity or standard debt structures typical of a pre-transaction SPAC. This balance sheet structure is inherently conservative regarding leverage, as there is no debt obligation, but it also lacks the operational cash flow to be self-sustaining without a merger. The current ratio is 1.64, which indicates a healthy short-term liquidity position relative to current liabilities, providing sufficient working capital to meet obligations until a business combination is finalized. Return on Equity (ROE) and Return on Assets (ROA) are both N/A, revealing that management effectiveness cannot be measured through traditional profitability ratios until the company transitions from a shell entity to an operating business with tangible assets and equity.
밸류에이션 평가
The trailing P/E ratio and forward P/E ratio are both N/A, as the company has not yet generated sufficient earnings to support a meaningful valuation multiple, and the absence of these metrics implies that the market is not pricing the stock based on current earnings expectations but rather on speculative merger potential. The price-to-book ratio is reported at -7.32, a negative figure that indicates the company's market capitalization is trading significantly below its book value, likely due to the specific accounting treatment of SPAC trusts or the inclusion of deferred underwriting costs in the equity calculation. The price-to-sales ratio and EV/EBITDA are both N/A, suggesting that alternative valuation methods based on revenue multiples or enterprise value are not applicable in the current pre-merger phase. The 52-week high is $10.49 and the 52-week low is $10.03, placing the current trading price within a very narrow band that suggests low volatility around the $10 redemption value typical for SPACs. The beta is N/A, meaning that the stock's price volatility relative to the broader market cannot be quantified yet, as the stock often moves independently of general market indices until a target company is identified. These valuation characteristics highlight that HCMA is priced as a speculative asset where the market cap of $341.04M serves as a proxy for the trust account balance rather than intrinsic value derived from cash flows or earnings power.
Growth & Income
Revenue growth and earnings growth rates are both N/A, as the company has not yet entered a phase of organic growth or earnings expansion, and the lack of historical data prevents any analysis of whether earnings are growing faster or slower than revenue. The company does not pay dividends, as indicated by the N/A dividend yield and payout ratio, which means that all available income is retained within the entity or held in trust for the eventual merger transaction. Instead of distributing income to shareholders, the company reinvests its resources into identifying and negotiating a merger with a private target business to achieve an operating profile. This growth and income profile is characterized by a complete absence of dividend yields and organic growth metrics, relying entirely on the successful execution of a business combination to generate future returns for investors.